MeiraGTx Holdings plc (MGTX)

MeiraGTx is evolving into a late-stage, manufacturing-enabled genetic medicine company with multiple near-term regulatory catalysts. Learn more about MGTX stock here.

MeiraGTx Holdings PLC (NASDAQ:MGTX) is one of the best gene therapy stocks to buy in 2026. The stock has gained around 25% year-to-date and soared more than 95% over the past year. Looking ahead, analysts believe the stock could explode more than 100% in the next 12 months as MeiraGTx advances ...

MeiraGTx (MGTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

According to InvestingPro analysis, the stock is currently trading above its Fair Value, placing it on the most overvalued list. The company’s performance has been noteworthy, as it continues to navigate the competitive landscape of the biotechnology sector. InvestingPro Tips highlight that three an…

The market expects MeiraGTx Holdings PLC (MGTX) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might …